Start-ups & Opportunities
Microbiotica raises $48 million led by British Business Bank for gut-bacteria pill
UK biotech Microbiotica raised £36 million ($48 million) in a Series C led by the British Business Bank on 16 October 2026 to take its gut-bacteria drug MB310 into Phase 2.
19 Oct 2026, 08:00 IST